Erin VanDyke/stoptheclot.org
Apr 3, 2026, 13:44
Erin VanDyke: Progress, Partnerships, and Patient Impact in VTE Care
Erin VanDyke, Vice President of NBCA Centers of Excellence, shared a post on LinkedIn:
“PHEW…March did not mess around.
Didn’t make it to Capitol Hill Day thanks to weather—but that didn’t slow things down one bit.
This month looked like:
- Supporting COEs across the country
- Visiting MyMichigan Health Midland, Corewell Health West Butterworth, and Ascension Sacred Heart
- Inservices with women’s health plus vein teams
- Celebrating VTE survivors (always the best part)
- Launching the Community DVT Excellence Program
- Welcoming Vein and Vascular Institute as our inaugural site
- Designating our FIRST pediatric VTE COE at Johns Hopkins All Children’s Hospital
- Hosting our first COE webinar
- Presenting at the Clot Care Summit
- Community outreach in Muskegon, MI
And through all of it—continuing to push awareness, education, and better care for patients impacted by blood clots.
Also grateful for the continued support from partners like Inari Medical, Penumbra Vascular, and Pfizer, helping advance education and awareness across so many of these initiatives.
Grateful for the people, the partnerships, and the progress…even if I need a nap
On to April.”
Proceed to the video attached to the post.
Other posts featuring Erin VanDyke on Hemostasis Today.
-
May 24, 2026, 00:54Andreas Ejlegard: The Promise of Smarter Antithrombotic Therapy with Cereno Scientific
-
May 24, 2026, 00:43Patient Advocacy and Clinical Excellence United at the European Certificate in Clinical Haemostasis – EHC
-
May 24, 2026, 00:41Mass General Brigham Research: Advancing the Future of Gene and Cell Therapy
-
May 23, 2026, 16:55Rahul Bhargava: Ensure Equal Recognition of Clinical Haematologists in Blood Cancer Clinical Trials
-
May 23, 2026, 16:44Brian O Mahony: World Haemophilia Day Receives Global WHO Recognition
-
May 23, 2026, 16:44Yusuf Hameed: Gene Therapy Could Reduce Lifetime Treatment Burden in Hemophilia A
-
May 23, 2026, 16:43Chokri Ben Lamine: Pacritinib Is a Key JAK Inhibitor for Cytopenic Myelofibrosis
-
May 23, 2026, 16:42Bartosz Hudzik: Bleeding Risk Alone Should Not Determine Treatment Intensity
-
May 23, 2026, 16:42Shimels Tessema: Celebrating the WHA Resolution on Hemophilia and Other Bleeding Disorders